Highlights
ASX: ACW       ACTINOGEN MEDICAL LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.056   -0.001 (1.75%)  0.056 - 0.059  179,624

Overview

 
Avg Volume (4 weeks):1,095,999
4 Weeks Range:0.043 - 0.059
4 Weeks Price Volatility (%):
81.25%
52 Weeks Range:0.04 - 0.066
52 Weeks Price Volatility (%):
61.54%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Actinogen Medical Limited, formerly Actinogen Limited, is a clinical-stage biotechnology company. The Company focuses on the treatment of Alzheimer's disease and age-related neurodegenerative diseases. The Company is engaged in treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. The Company's Xanamem is a drug under development for the treatment of Alzheimer's disease, which is designed to block the production of cortisol in the brain. Xanamem's mechanism of action is to block the activity of a specific enzyme in the brain, the 11B-HSD1 enzyme. It focuses on Xanamem in the clinical areas, including Diabetes-Cognitive dysfunction, Cognitive dysfunction in Parkinson's Disease, Post Traumatic Stress Disorder (PTSD), Cognitive dysfunction in schizophrenia and depression, and Cardiovascular disease-Post myocardial infarction. It focuses on Phase II XanADu efficacy and safety study with mild Alzheimer's disease patients.

  Be the first to like this.
 


 

595  477  693  9392 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 E2E 0.02+0.004 
 AUZ 0.0440.00 
 BSM 0.015+0.002 
 SRO 0.0020.00 
 JAT 0.091+0.011 
 VEC 0.023-0.002 
 CDX 0.047-0.001 
 WSI 0.021+0.005 
 IAM 0.009-0.001 
 MDI 0.0060.00 
Partners & Brokers